Aktie A144DY MOREPEN LABORATORIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Morepen Laboratories Limited NSE India S.E.

Aktien

A144DY

INE083A01026

MOREPENLAB

Verzögert NSE India S.E.
Andere Börsenplätze
 09:12:20 18.05.2024 		% 5 Tage % 1. Jan.
47,9 INR +2,24 % Intraday Chart für Morepen Laboratories Limited +3,79 % -1,34 %
30.03. Morepen Laboratories Limited gibt den Rücktritt von Lalit Kumar Baregama, Chief Growth Officer, bekannt CI
01.03. Morepen Laboratories Limited kündigt die Beförderung von Amita Sharma zum Chief Operating Officer -API an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Morepen Laboratories : Change in the date of appointment of Mr. Nishant Jayesh Doshi, V P - Corp. Fin. & Investor Relations ('SMP') Change in Senior Management Personnel - Mr. Rajesh Kumar Singh
Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer
Morepen Laboratories : Dr. Morepen Partners with OptiBiotix to Deliver Safe, ScienceBacked Weight Management Solution to India
Morepen Laboratories Limited Announces the Promotion of Amita Sharma to Chief Operating Officer -API
Morepen Laboratories Limited Approves the Appointment of Vikas Sharma, Talent Acquisition & HRBP, Functional Head
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Morepen Laboratories Limited Announces Resignation of Rolli Saxena, General Manager - HR, Being A Functional Head and Senior Management Personnel
Morepen Laboratories Limited Appoints Shantanu Tuli as President -Strategy and Brand Identity, Effective from December 1, 2023
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Morepen Laboratories to Transfer Formulation Distribution and Marketing Business to Subsidiary
Morepen Laboratories : Investors presentation - Q1' FY 2023-24
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Morepen Laboratories' Net Profit Drops in Fiscal Q4
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
US FDA Clears Morepen Laboratories' Baddi, India
Morepen Laboratories Forms Wholly-Owned Subsidiary
Morepen Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Morepen Laboratories : Transcript of EGM dated March 05, 2022  Audited Financial results for the quarter and financial year ended March 31, 2022  Unaudited financial results for the quarter and nine months ended December 31, 2021  Unaudited Financial results for the quarter and half year ended September 30, 2021  Unaudited Financial results for the quarter ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A144DY Aktie
  4. A144DY Aktie
  5. Nachrichten Morepen Laboratories Limited
  6. Andere Sprachen